Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Cabergoline in Treatment of Methamphetamine-Dependent Patients and Its Effect on Serum Level of Glial Cell-Derived Neurotrophic Factor: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Masoumeh Amin-Esmaeili
Masoumeh Amin-Esmaeili

Associate Professor of Psychiatry

Iranian National Center for Addiction Studies (INCAS)

Tehran University of Medical Sciences

All Documents
1. Drug Use and Its Correlated Factors Among University Students in Tehran, Journal of Substance Use (2025)
2. Social Capital and Major Depressive Disorder Among Youth in Iran, BMC Psychiatry (2025)
3. Alcohol Use, Alcohol Use Disorder and Heavy Episodic Drinking in the Eastern Mediterranean Region: A Systematic Review, Addiction (2024)
4. Drug Use and Its Correlated Factors Among University Students in Tehran, Journal of Substance Use (2024)
5. Managing the Dual Diagnosis Dilemma of Bipolar Disorder and Substance Abuse in Clinical Settings, Journal of Dual Diagnosis (2024)
6. Reduced Drug Use As an Alternative Valid Outcome in Individuals With Stimulant Use Disorders: Findings From 13 Multisite Randomized Clinical Trials, Addiction (2024)
7. The Effectiveness of Universal Educational Interventions for Prevention of Illicit Drug Use Among University Students: A Systematic Review, Iranian Journal of Public Health (2024)
8. Trajectories of Craving in the Course of Pharmacotherapy Trials for Methamphetamine Use Disorder, Addiction (2024)
9. Co-Occurrence of Aggression and Suicide Attempt Among Young People and Related Factors: Findings From Iranian Youth Cohort Study in Ravansar, Archives of Iranian Medicine (2023)
10. Iran Quality of Care in Medicine Program (Iqcamp): Design and Outcomes, Archives of Iranian Medicine (2023)
11. Iran Quality of Care in Medicine Program (Iqcamp): Design and Outcomes, Archives of Iranian Medicine (2023)
12. Model-Robust Inference for Clinical Trials That Improve Precision by Stratified Randomization and Covariate Adjustment, Journal of the American Statistical Association (2023)
13. Online Gaming and Internet Gaming Disorder in Iran: Patterns, Motivations, and Correlates, Current Psychology (2023)
14. Physical Activity Patterns, Circadian Rhythms, and Aggressive and Suicidal Behavior Among a Larger Sample of the General Population Aged 15 to 34 Years, Journal of Clinical Medicine (2023)
15. Prevalence and Determinants of Opioid Use Disorder Among Long-Term Opiate Users in Golestan Cohort Study, BMC Psychiatry (2023)
16. Psychometric Properties of the Persian Version of the Gaming Motivation Scale, Psychiatry Investigation (2023)
17. Six-Year Follow-Up of People Who Use Methamphetamine in Iran: A Case Series Study, International Journal of High Risk Behaviors and Addiction (2023)
18. Hiv Prevalence Among Non-Injecting People Who Use Drugs and Related Factors in Iran: A Systematic Review and Meta-Analysis, Drug and Alcohol Review (2022)
19. Impact of Early, Weekly Drinking on Latent Classes of Alcohol Involvement Progression and Recovery: Evidence From the Nesarc Waves 1 and 2, Addictive Behaviors Reports (2022)
20. Major Depressive Disorder in Iran: Epidemiology, Health Care Provision, Utilization, and Challenges, Archives of Iranian Medicine (2022)
21. Mortality and Negative Outcomes of Opioid Use and Opioid Use Disorder: A 6-Year Follow-Up Study, Addiction (2022)
22. Psychometric Assessment of the Motives for Online Gaming Questionnaire Among Iranian Gamers, Psychiatry Investigation (2022)
23. Validity of Self-Reports of Medication Treatment of Depression in General Population Surveys, Pharmacoepidemiology and Drug Safety (2022)
24. Assessing Risk Behaviours in the Iranian General Population: Results From the Iranian Mental Health Survey; [Evaluation Des Comportements a Risque Dans La Population Generale Iranienne: Resultats De L’Enquete Iranienne Sur La Sante Mentale], Eastern Mediterranean Health Journal (2021)
25. Assessing Risk Behaviours in the Iranian General Population: Results From the Iranian Mental Health Survey; [Evaluation Des Comportements a Risque Dans La Population Generale Iranienne: Resultats De L’Enquete Iranienne Sur La Sante Mentale], Eastern Mediterranean Health Journal (2021)
26. Cluster Analysis of Risky Behaviors Among the Youth in Western Iran: Determining Correlates and Comparing Clusters Based on Severity of Disability and Attitude Toward Mental Health Help-Seeking, Indian Journal of Psychiatry (2021)
27. Comment: Inference After Covariate-Adaptive Randomisation: Aspects of Methodology and Theory, Statistical Theory and Related Fields (2021)
28. Data Management in Substance Use Disorder Treatment Research: Implications From Data Harmonization of National Institute on Drug Abuse-Funded Randomized Controlled Trials, Clinical Trials (2021)
29. Evidence for an Increase in Cannabis Use in Iran – a Systematic Review and Trend Analysis, PLoS ONE (2021)
30. Metabolomics Reveals Biomarkers of Opioid Use Disorder, Translational Psychiatry (2021)
31. Patterns of Reduced Use and Abstinence in Multi-Site Randomized Controlled Trials of Pharmacotherapies for Cocaine and Methamphetamine Use Disorders, Drug and Alcohol Dependence (2021)
32. Remission and Treatment Augmentation of Depression in the United States, Journal of Clinical Psychiatry (2021)
33. Hepatitis B Virus Infection Among People Who Use Drugs in Iran: A Systematic Review, Meta-Analysis, and Trend Analysis, Harm Reduction Journal (2020)
34. Hiv Prevalence Among People Who Inject Drugs (Pwid) and Related Factors in Iran: A Systematic Review, Meta-Analysis and Trend Analysis, Addiction (2020)
35. Tramadol Use and Public Health Consequences in Iran: A Systematic Review and Meta-Analysis, Addiction (2020)
36. Validation of Addiction Severity Index (Asi) for Assessment of Psychiatric Comorbidity in Multi-Site Randomized Controlled Trials, Journal of Dual Diagnosis (2020)
37. Misuse of Prescribed Opioids in the United States, Pharmacoepidemiology and Drug Safety (2019)
38. Prevalence of Psychiatric Disorders and Associated Factors Among the Youth in Ravansar, Iran, Archives of Iranian medicine (2019)
39. Province-Level Prevalence of Psychiatric Disorders: Application of Small-Area Methodology to the Iranian Mental Health Survey (Iranmhs), Iranian Journal of Psychiatry (2019)
40. Adaptation and Validation of Short Scales for Assessment of Psychological Distress in Iran: The Persian K10 and K6, International Journal of Methods in Psychiatric Research (2018)
41. Ambiguities in Existing Iranian National Policies Addressing Excessive Gaming Commentary On: Policy Responses to Problematic Video Game Use: A Systematic Review of Current Measures and Future Possibilities (Kiraly Et Al., 2018), Journal of Behavioral Addictions (2018)
42. Bipolar Features in Major Depressive Disorder: Results From the Iranian Mental Health Survey (Iranmhs), Journal of Affective Disorders (2018)
43. Cluster Analysis of Psychiatric Profile, Its Correlates, and Using Mental Health Services Among the Young People Aged 15–34: Findings From the First Phase of Iranian Youth Cohort in Ravansar, Social Psychiatry and Psychiatric Epidemiology (2018)
44. Global Scientific Production on Illicit Drug Addiction: A Two-Decade Analysis, European Addiction Research (2018)
45. Incidence and Cost of Non-Fatal Burns in Iran: A Nationwide Population-Based Study, International Journal of Injury Control and Safety Promotion (2018)
46. Major Anxiety Disorders in Iran: Prevalence, Sociodemographic Correlates and Service Utilization, BMC Psychiatry (2018)
47. Methods for Calculation of Per Capita Alcohol Consumption in a Muslim Majority Country With a Very Low Drinking Level: Findings From the 2011 Iranian Mental Health Survey, Drug and Alcohol Review (2018)
48. Pharmacological Therapies for Management of Opium Withdrawal, Cochrane Database of Systematic Reviews (2018)
49. Prevalence and Costs of Complementary/Alternative Medicine Among Traumatic Patients in Iran: A Nationwide Population-Based Study, Iranian Journal of Public Health (2018)
50. Psychiatric Disorders Among People Living With Hiv/Aids in Iran: Prevalence, Severity, Service Utilization and Unmet Mental Health Needs, Journal of Psychosomatic Research (2018)
51. Alcohol Use Disorders in Iran: Prevalence, Symptoms, Correlates, and Comorbidity, Drug and Alcohol Dependence (2017)
52. Direct and Indirect Costs of Nonfatal Road Traffic Injuries in Iran: A Population-Based Study, Traffic Injury Prevention (2017)
53. Drop-Out From a Drug Treatment Clinic and Associated Reasons; [Taux D’Abandon Dans Un Centre De Traitement De La Dependance Aux Drogues Et Raisons Associees], Eastern Mediterranean Health Journal (2017)
54. Explaining Socioeconomic Inequalities in Illicit Drug Use Disorders in Iran, Medical Journal of the Islamic Republic of Iran (2017)
55. Inclusion of Gaming Disorder in the Diagnostic Classifications and Promotion of Public Health Response, Journal of Behavioral Addictions (2017)
56. Out-Of-Pocket Cost of Drug Abuse Consequences: Results From Iranian National Mental Health Survey; [Cout Des Paiements Directs Engendres Par L’Abus De Substances Psychoactives: Resultats De L’Enquete Nationale Iranienne Sur La Sante Mentale], Eastern Mediterranean Health Journal (2017)
57. The Persian Cohort: Providing the Evidence Needed for Healthcare Reform, Archives of Iranian medicine (2017)
58. The Persian Cohort: Providing the Evidence Needed for Healthcare Reform, Archives of Iranian Medicine (2017)
59. The Prevalence of Illicit Substance Use Among Students of Medical Sciences in Tehran: Results From Four Repeated Surveys From 2006 to 2009, Journal of Child and Adolescent Substance Abuse (2017)
60. Use of Amphetamine-Type Stimulants in the Islamic Republic of Iran, 2004–2015: A Review; [Consommation De Stimulants De Type Amphetamines En Republique Islamique D’Iran, 2004-2005: Analyse], Eastern Mediterranean Health Journal (2017)
61. Use of Amphetamine-Type Stimulants in the Islamic Republic of Iran, 2004–2015: A Review; [Consommation De Stimulants De Type Amphetamines En Republique Islamique D’Iran, 2004-2005: Analyse], Eastern Mediterranean Health Journal (2017)
62. Correlation of Mental Illness and Hiv/Aids Infection, Tehran University Medical Journal (2016)
63. Epidemiology of Illicit Drug Use Disorders in Iran: Prevalence, Correlates, Comorbidity and Service Utilization Results From the Iranian Mental Health Survey, Addiction (Abingdon# England) (2016)
64. Incidence of Fall-Related Injuries in Iran: A Population-Based Nationwide Study, Injury (2016)
65. Profile of People Who Inject Drugs in Tehran, Iran, Acta Medica Iranica (2016)
66. Psychiatric Disorders Are Associated With an Increased Risk of Injuries: Data From the Iranian Mental Health Survey (Iranmhs), Iranian Journal of Public Health (2016)
67. High Hepatitis C Virus Prevalence Among Drug Users in Iran: Systematic Review and Meta-Analysis of Epidemiological Evidence (2001-2012), International Journal of Infectious Diseases (2015)
68. Incidence of Self-Reported Interpersonal Violence Related Physical Injury in Iran, Iranian Red Crescent Medical Journal (2015)
69. Latent Class Analysis of Dsm-5 Criteria for Opioid Use Disorders: Results From the Iranian National Survey on Mental Health, European Addiction Research (2015)
70. Population-Based Incidence and Cost of Non-Fatal Injuries in Iran: A Consistent Under-Recognized Public Health Concern, Public Health (2015)
71. Transition to Injecting Drug Use in Iran: A Systematic Review of Qualitative and Quantitative Evidence, International Journal of Drug Policy (2015)
72. Twelve-Month Prevalence and Correlates of Psychiatric Disorders in Iran: The Iranian Mental Health Survey, 2011, Archives of Iranian Medicine (2015)